Literature DB >> 2788097

Pharmacology of electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry.

M F Suaud-Chagny1, M Buda, F G Gonon.   

Abstract

Dopamine (DA) release was evoked by electrical stimulation of the dopaminergic pathway. Electrically evoked DA release was monitored in the olfactory tubercle of anesthetized rats using differential pulse amperometry (DPA) combined with a treated carbon fiber electrode. Systemic injection of alpha-methyl-para-tyrosine (AMPT 250 mg/kg), NSD-1015 (50 mg/kg), reserpine (5 mg/kg), d,l-apomorphine (400 micrograms/kg) decreased evoked DA release while pargyline (75 mg/kg), nomifensine (4 and 20 mg/kg), methylphenidate (10 mg/kg), amphetamine (0.5, 2 and 5 mg/kg), sulpiride (20 mg/kg) and haloperidol (50 micrograms/kg) enhanced it. Thus, evoked DA release as measured indirectly by DPA is dependent upon synthesis, catabolism and vesicular processes. It can be also affected by DA releasers, DA re-uptake inhibitors, DA agonists and DA antagonists. These results suggest that under our experimental conditions all the drugs tested act directly on DA nerve terminals to modulate in vivo the evoked DA release.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788097     DOI: 10.1016/0014-2999(89)90468-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Two simultaneously working storage pools of dopamine in mouse caudate and nucleus accumbens.

Authors:  L Yavich
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 2.  Animal models to guide clinical drug development in ADHD: lost in translation?

Authors:  Jeffery R Wickens; Brian I Hyland; Gail Tripp
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

3.  Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo.

Authors:  Eric S Ramsson; Daniel P Covey; David P Daberkow; Melissa T Litherland; Steven A Juliano; Paul A Garris
Journal:  J Neurochem       Date:  2011-05-03       Impact factor: 5.372

4.  Heterogeneous extracellular dopamine regulation in the subregions of the olfactory tubercle.

Authors:  Jinwoo Park; Ken T Wakabayashi; Caitlin Szalkowski; Rohan V Bhimani
Journal:  J Neurochem       Date:  2017-06-20       Impact factor: 5.372

5.  High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat.

Authors:  Eric S Ramsson; Christopher D Howard; Dan P Covey; Paul A Garris
Journal:  J Neurochem       Date:  2011-08-25       Impact factor: 5.372

6.  Tyrosine Hydroxylase Inhibition in Substantia Nigra Decreases Movement Frequency.

Authors:  Michael F Salvatore; Tamara R McInnis; Mark A Cantu; Deana M Apple; Brandon S Pruett
Journal:  Mol Neurobiol       Date:  2018-07-28       Impact factor: 5.590

7.  Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals.

Authors:  D P Daberkow; H D Brown; K D Bunner; S A Kraniotis; M A Doellman; M E Ragozzino; P A Garris; M F Roitman
Journal:  J Neurosci       Date:  2013-01-09       Impact factor: 6.167

Review 8.  Abnormal striatal dopamine transmission in schizophrenia.

Authors:  Jerome Brunelin; Shirley Fecteau; Marie-Françoise Suaud-Chagny
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.